These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19411864)

  • 1. Cancer stem cells: seeds of growth in osteosarcoma.
    Gillette J; Nielsen-Preiss S
    Cancer Biol Ther; 2009 Mar; 8(6):553-4. PubMed ID: 19411864
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer stem cells in osteosarcoma.
    Brown HK; Tellez-Gabriel M; Heymann D
    Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of stem cell attributes in human osteosarcoma cell lines.
    Wang L; Park P; Lin CY
    Cancer Biol Ther; 2009 Mar; 8(6):543-52. PubMed ID: 19242128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
    Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
    Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
    Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
    J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
    Wang W; Chen D; Zhu K
    J Exp Clin Cancer Res; 2018 Feb; 37(1):37. PubMed ID: 29475441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics of osteosarcoma.
    Bernardini G; Laschi M; Geminiani M; Santucci A
    Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial Note: Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation.
    PLOS ONE Editors
    PLoS One; 2024; 19(8):e0308114. PubMed ID: 39146314
    [No Abstract]   [Full Text] [Related]  

  • 12. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
    Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
    Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
    Lu J; Song G; Tang Q; Yin J; Zou C; Zhao Z; Xie X; Xu H; Huang G; Wang J; Lee DF; Khokha R; Yang H; Shen J
    Oncogene; 2017 Jan; 36(2):231-241. PubMed ID: 27270422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of transcriptome-wide m
    Wang Y; Zeng L; Liang C; Zan R; Ji W; Zhang Z; Wei Y; Tu S; Dong Y
    Epigenomics; 2019 Nov; 11(15):1693-1715. PubMed ID: 31650864
    [No Abstract]   [Full Text] [Related]  

  • 16. GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma.
    Dong J; Bi B; Zhang L; Gao K
    Oncol Rep; 2016 Sep; 36(3):1585-91. PubMed ID: 27460987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
    Zhao D; Wang S; Chu X; Han D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9.
    Zhao F; Lv J; Gan H; Li Y; Wang R; Zhang H; Wu Q; Chen Y
    Int J Clin Exp Pathol; 2015; 8(2):1451-8. PubMed ID: 25973030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
    Roundhill EA; Jabri S; Burchill SA
    Cancer Lett; 2019 Jul; 453():142-157. PubMed ID: 30910588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.